Accretion and Dilution

An action is accretive if it increases a per-share or per-unit metric, and dilutive if it decreases it. The words attach to whatever metric is in question: EPS accretive, margin accretive, value accretive, book-value accretive. At its core the concept is simple, but the phrase "margin accretive" and "value accretive" trip people up because they measure different things.

The three common senses

EPS accretive or dilutive. The most frequent use, applied to acquisitions, buybacks, and share issuance. A deal is EPS accretive if pro-forma earnings per share after the transaction exceed standalone EPS. Buying back stock below a certain threshold is accretive; issuing shares to fund a low-return use is dilutive.

Margin accretive or dilutive. Used at the business-mix level. Adding a product line, segment, or acquisition is margin accretive if its margin is higher than the company's existing blended margin, pulling the average up. A software company buying a services business often takes a margin-dilutive hit even if the deal is EPS accretive, because services carry lower margins.

Value accretive or dilutive. The most important and most abused. An action is value accretive only if it earns a return above the cost of capital. A deal can be EPS accretive yet value dilutive, because EPS accretion can be manufactured with cheap debt while still destroying economic value.

Worked example: an EPS-accretive but potentially value-dilutive deal

Company A earns $200m on 100m shares, so standalone EPS is $2.00. It acquires Company B, which earns $40m, by issuing 15m new shares.

• Combined earnings = $200m + $40m = $240m
• Combined shares = 100m + 15m = 115m
• Pro-forma EPS = $240m / 115m = $2.087

EPS rose from $2.00 to $2.09, so the deal is EPS accretive by about 4%. But accretion alone does not tell you whether value was created. If Company A paid a rich premium and B's earnings grow slowly, the return on the purchase price may fall short of the cost of capital, making the deal value dilutive even though the headline EPS number went up. This is the trap: management teams often defend deals by pointing to EPS accretion while ignoring whether the return clears the hurdle rate.

The right test

To judge value accretion, compare the return on invested capital from the action against the cost of that capital. A buyback is value accretive when the earnings yield on the repurchased shares exceeds the after-tax cost of the cash or debt used. An acquisition is value accretive when the target's cash returns on the total purchase price beat the acquirer's WACC. EPS accretion is a necessary marketing point, not proof of value.

Why the distinction matters

The cleanest way to be fooled is to accept "the deal is accretive" without asking accretive to what. Cheap debt makes almost any cash-generating acquisition EPS accretive in year one. Margin accretion tells you about mix, not returns. Only value accretion, measured against the cost of capital, tells you whether shareholders are better off.